Mast Group Ltd
Issa Isaac NGOM is an accomplished professional with a diverse background in project management, microbiology, and pharmacy. Currently serving as a Key Account Manager at Mast Group Ltd since January 2022, Issa Isaac NGOM previously held the position of IT Project Manager at ib - groupe Cegos, where responsibilities included leading Agile project teams, user needs analysis, and project documentation. Prior experience also includes roles as a Pharmacy Assistant and Researcher PhD Candidate at Aix-Marseille Université, focusing on gut microbiota exploration through multi-OMICS techniques. Issa Isaac NGOM has a Doctor of Philosophy in Microbiology from Aix-Marseille University, alongside master's degrees in Human Pathologies and Phytochemistry, and a Doctor of Pharmacy degree from Université Cheikh Anta Diop de Dakar.
This person is not in any offices
Mast Group Ltd
1 followers
Mast Group Ltd is a UK based leading independent European manufacturer and supplier of clinical diagnostic products. Established in Liverpool in 1957, Mast Group has grown into a multinational company exporting globally. The corporate headquarters Mast Group Ltd are based in Bootle and has subsidiary companies in Reinfeld (Mast Diagnostica GmbH) and Amiens, France (Mast Diagnostic). Mast Group were among the first companies to commercialise the antibiotic disc, and continue to work with major pharmaceutical companies worldwide in the development of new and exciting products. Mast Group focuses on the susceptibility, identification and resistance along with offering molecular and immunochemistry solutions for the IVD market. This is achieved through the investment in personnel, R&D and infrastructure, including state of the art manufacturing facilities in Merseyside. This enables Mast Group to provide tools to aid in the diagnosis of clinical disease, from pioneering antibiotic susceptibility testing to novel molecular solutions, Mast Group continues to develop products for the ever changing IVD market, creating solutions to support clinical diagnosis today and into the future.